SCHEMBL4175332

SCHEMBL4175332

COc1cncc(NC(=O)c2cc(NC(=O)c3ccc(C)c(C)c3)ccc2C)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 13/20 0.67
CSF1R P07333 1/20 0.56
IMPDH2 P12268 1/20 0.53
BTK Q06187 2/20 0.52
BLK P51451 1/20 0.52
KCNQ3 O43525 1/20 0.52
KCNQ2 O43526 1/20 0.52
CYP2C9 P11712 3/20 0.51
KDM4E B2RXH2 1/20 0.51
MEN1 O00255 1/20 0.51
NPC1 O15118 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
MAPT P10636 1/20 0.51
CYP2C19 P33261 1/20 0.51
KMT2A Q03164 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
LCK P06239 2/20 0.51
ABL1 P00519 1/20 0.50
KIT P10721 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3934251 0.92 BRAF (0.64) BRAFCSF1RIMPDH2BTKBLK
SCHEMBL3936045 0.89 BRAF (0.62) BRAFCSF1RBTKBLKKCNQ3
SCHEMBL3938207 0.88 BRAF (0.72) BRAFCSF1RBTKCYP2C9LCK
SCHEMBL3934757 0.87 BRAF (0.62) BRAFCSF1RBTKCYP2C9NPC1
SCHEMBL3934373 0.86 BRAF (0.71) BRAFCSF1RBTKCYP2C9NPC1
SCHEMBL3934779 0.84 BRAF (0.77) BRAFCSF1RBTKBLKCYP2C9
SCHEMBL3933731 0.83 BRAF (0.65) BRAFBTKBLKCYP2C9LCK
SCHEMBL3942246 0.82 BRAF (0.57) BRAFCSF1RBTKCYP2C9NPC1
SCHEMBL3943854 0.81 BRAF (0.55) BRAFCSF1RBTKBLKNPC1
SCHEMBL3944066 0.81 BRAF (0.63) BRAFCSF1RBTKCYP2C9LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831198-B1 PYRIDINE CARBOXAMIDE DERIVATIVES FOR USE AS ANTICANCER AGENTS ASTRAZENECA AB (SE) 2009-04-08 EP disclosed